Michael Wendland Selected Research

Michael Wendland Research Topics

5	Stroke (Strokes) 03/2013 - 07/2005
4	Brain Injuries (Brain Injury) 03/2013 - 07/2005
3	Neoplasms (Cancer) 01/2015 - 05/2008
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2013 - 02/2010
1	Sarcoma (Soft Tissue Sarcoma) 01/2015
1	Necrosis 01/2015
1	Glioma (Gliomas) 12/2012
1	Hypoxia (Hypoxemia) 02/2010
1	Gliosis 02/2010
1	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2009
1	Ovarian Neoplasms (Ovarian Cancer) 05/2008

4	Erythropoietin FDA Link 03/2013 - 07/2005
2	salicylhydroxamic acid (SHAM)IBA 03/2013 - 05/2009
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 01/2015
1	Ferrosoferric Oxide (Magnetite)FDA Link 01/2015
1	IronIBA 01/2015
1	Green Fluorescent ProteinsIBA 03/2013
1	LuciferasesIBA 12/2012
1	Biological ProductsIBA 12/2012
1	RibonucleoproteinsIBA 12/2012
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2012
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2012
1	Caspase 3 (Caspase-3)IBA 02/2010
1	Glial Fibrillary Acidic ProteinIBA 02/2010
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 02/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2010
1	Folic Acid (Vitamin M)FDA LinkGeneric 05/2008
1	ferric oxide (iron oxide)IBA 05/2008
1	Contrast MediaIBA 05/2008
1	GadoliniumIBA 05/2008

1	Intraventricular Injections 03/2013